Cytoskeleton protein 4.1R suppresses murine keratinocyte cell hyperproliferation via activating the Akt/ERK pathway

Lixiang Chen1, Ting Wang1, Xiang Ji2

  • 1School of Life Science, Zhengzhou University, No.100 Science Avenue, Zhengzhou, 450001, China.

Experimental Cell Research
|September 29, 2019
PubMed

Insights

The protein 4.1R regulates epidermal growth factor receptor (EGFR) activation in skin cells. Loss of 4.1R leads to increased EGFR signaling and keratinocyte hyperproliferation, contributing to skin conditions.

Area of Science:

  • Cell Biology
  • Dermatology
  • Molecular Biology

Background:

  • Epidermal growth factor receptor (EGFR) is crucial for skin development and homeostasis.
  • EGFR dysregulation causes hyperproliferation, hair follicle defects, skin lesions, and tumorigenesis.
  • Mechanisms of EGFR activation and signaling require further elucidation.

Purpose of the Study:

  • Investigate the role of 4.1R, a FERM family protein, in EGFR activation and signaling within keratinocytes.
  • Determine how 4.1R influences EGFR-mediated downstream pathways.
  • Identify 4.1R as a potential regulator of EGFR signaling in skin.

Main Methods:

  • Immunohistochemical analysis of murine skin samples.
  • Analysis of keratinocyte proliferation and signaling pathways (Akt/ERK).
  • Coimmunoprecipitation and immunofluorescent staining to assess protein interactions.

Main Results:

  • 4.1R knockout keratinocytes exhibit augmented proliferation potential.
  • Loss of 4.1R enhances EGFR expression and phosphorylation, leading to increased Akt/ERK signaling.
  • 4.1R directly binds to EGFR, impairing its activation and downstream signaling.

Conclusions:

  • 4.1R acts as a negative regulator of EGFR activation in keratinocytes.
  • Deficiency in 4.1R sustains aberrant EGFR signaling, promoting hyperproliferation.
  • 4.1R is a novel regulator of EGFR signaling with implications for skin biology and disease.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K